Display options
Share it on

Thromb J. 2012 May 07;10(1):6. doi: 10.1186/1477-9560-10-6.

Endothelial cells influence the sodium nitroprusside mediated inhibition of platelet aggregation by an as yet unkown pathway.

Thrombosis journal

Hans-Georg Topf, Manfred Rauh, Wolfgang Rascher, Jörg Dötsch, Jens M Klinge

Affiliations

  1. Klinik für Kinder und Jugendliche, University of Erlangen-Nuremberg, Loschgestr 15, 91054, Erlangen, Germany. [email protected].

PMID: 22564812 PMCID: PMC3528661 DOI: 10.1186/1477-9560-10-6

Abstract

UNLABELLED: The clinical use of Sodium nitroprusside (SNP) may be associated with an alteration of platelet function. The main focus of this study was the effect of SNP on platelet aggregation in the absence or presence of endothelial cells.

METHODS: Platelets were incubated with different concentrations of SNP with and without endothelial cells. Platelet aggregation was induced by ADP.

RESULTS: Platelet aggregation was significantly inhibited by all concentrations of SNP. Endothelial cells significantly increased this inhibitory effect of SNP. Time course studies showed an inverse correlation of incubation time to platelet aggregation inhibition in the absence of endothelial cells, and a direct correlation in the presence of endothelial cells. Blocking platelet and endothelial cell guanylate cyclase with 1 H-(1,2,4)-oxadiazolo(4,3-a) quinoxalin-1-one (ODQ), or pretreatment of the endothelial cells with cyclooxygenase - inhibitors, had no influence on the increased inhibitory effect of the endothelial cells. Cyanide reversed the inhibitory effect of SNP completely.

CONCLUSION: Endothelial cells play an important role in the SNP mediated inhibition of platelet aggregation. The effect is reversible only by cyanide, not by blocking classical NO signal transduction.

References

  1. Ann Thorac Surg. 1998 May;65(5):1335-41 - PubMed
  2. N Engl J Med. 1990 Jul 5;323(1):27-36 - PubMed
  3. Gen Pharmacol. 1997 May;28(5):671-3 - PubMed
  4. J Crit Care. 2000 Mar;15(1):30-5 - PubMed
  5. Crit Care Med. 2003 Jul;31(7):2010-4 - PubMed
  6. Nurs Clin North Am. 1991 Jun;26(2):437-50 - PubMed
  7. Blood Coagul Fibrinolysis. 1996 Oct;7(7):678-83 - PubMed
  8. Haematologia (Budap). 2000;30(2):81-90 - PubMed
  9. Thromb Res. 1998 Apr 15;90(2):83-91 - PubMed
  10. Dig Dis Sci. 1986 Feb;31(2 Suppl):6S-19S - PubMed
  11. Br J Pharmacol. 1987 Sep;92(1):181-7 - PubMed
  12. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1480-5 - PubMed
  13. J Perinat Med. 1998;26(3):219-24 - PubMed
  14. Crit Care Med. 2002 Nov;30(11):2560-5 - PubMed
  15. J Hypertens. 1993 Dec;11(12):1369-73 - PubMed
  16. Cardiovasc Drugs Ther. 1995 Aug;9(4):619-29 - PubMed
  17. Lancet. 1998 Apr 18;351(9110):1181-2 - PubMed
  18. Thromb J. 2004 Nov 15;2(1):11 - PubMed
  19. Circulation. 1982 Dec;66(6):1299-307 - PubMed
  20. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7240-4 - PubMed
  21. J Cardiovasc Pharmacol. 1986;8 Suppl 8:S102-6 - PubMed
  22. Methods Enzymol. 1996;269:12-25 - PubMed
  23. Br J Pharmacol. 1987 Nov;92(3):639-46 - PubMed
  24. Platelets. 2011;22(1):8-19 - PubMed
  25. Kidney Int Suppl. 2003 May;(84):S22-4 - PubMed
  26. Cardiovasc Res. 1993 Jul;27(7):1380-2 - PubMed
  27. Curr Opin Pediatr. 2005 Apr;17(2):210-4 - PubMed
  28. Biochem Biophys Res Commun. 2000 Dec 20;279(2):412-9 - PubMed
  29. Intensive Care Med. 2000 Mar;26(3):330-5 - PubMed
  30. J Pediatr. 1985 Jan;106(1):102-10 - PubMed

Publication Types